SARTORIUS (UNSP.ADS)/1/5 (SRT0) - Total Assets
Based on the latest financial reports, SARTORIUS (UNSP.ADS)/1/5 (SRT0) holds total assets worth €9.87 Billion EUR (≈ $11.54 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore SARTORIUS (UNSP.ADS)/1/5 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
SARTORIUS (UNSP.ADS)/1/5 - Total Assets Trend (2022–2025)
This chart illustrates how SARTORIUS (UNSP.ADS)/1/5's total assets have evolved over time, based on quarterly financial data. See SARTORIUS (UNSP.ADS)/1/5 (SRT0) net assets for net asset value and shareholders' equity analysis.
SARTORIUS (UNSP.ADS)/1/5 - Asset Composition Analysis
Current Asset Composition (December 2025)
SARTORIUS (UNSP.ADS)/1/5's total assets of €9.87 Billion consist of 18.2% current assets and 81.8% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 5.6% |
| Accounts Receivable | €224.70 Million | 2.3% |
| Inventory | €792.20 Million | 8.2% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €1.83 Billion | 18.8% |
| Goodwill | €3.47 Billion | 35.7% |
Asset Composition Trend (2022–2025)
This chart illustrates how SARTORIUS (UNSP.ADS)/1/5's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see SARTORIUS (UNSP.ADS)/1/5 market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SARTORIUS (UNSP.ADS)/1/5's current assets represent 18.2% of total assets in 2025, a decrease from 29.0% in 2022.
- Cash Position: Cash and equivalents constituted 5.6% of total assets in 2025, up from 2.4% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 53.0% of total assets, an increase from 42.0% in 2022.
- Asset Diversification: The largest asset category is goodwill at 35.7% of total assets.
SARTORIUS (UNSP.ADS)/1/5 Competitors by Total Assets
Key competitors of SARTORIUS (UNSP.ADS)/1/5 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Blue Sail Medical Co Ltd
SHE:002382
|
China | CN¥16.12 Billion |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Ocumetics Technology Corp
V:OTC
|
Canada | CA$1.15 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
|
Osteopore Ltd
AU:OSX
|
Australia | AU$2.77 Million |
|
Nyxoah
BR:NYXH
|
Belgium | €93.60 Million |
SARTORIUS (UNSP.ADS)/1/5 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.91 | 1.46 | 1.46 |
| Quick Ratio | 0.52 | 0.93 | 0.92 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-189.80 Million | €678.10 Million | €669.10 Million |
SARTORIUS (UNSP.ADS)/1/5 - Advanced Valuation Insights
This section examines the relationship between SARTORIUS (UNSP.ADS)/1/5's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.65 |
| Latest Market Cap to Assets Ratio | 0.97 |
| Asset Growth Rate (YoY) | -3.8% |
| Total Assets | €9.72 Billion |
| Market Capitalization | $9.40 Billion USD |
Valuation Analysis
Near Book Valuation: The market values SARTORIUS (UNSP.ADS)/1/5's assets close to their book value (0.97x), suggesting investors view the company's assets at approximately fair value.
Slight Asset Contraction: SARTORIUS (UNSP.ADS)/1/5's assets decreased by 3.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for SARTORIUS (UNSP.ADS)/1/5 (2022–2025)
The table below shows the annual total assets of SARTORIUS (UNSP.ADS)/1/5 from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €9.72 Billion ≈ $11.36 Billion |
-3.82% |
| 2024-12-31 | €10.10 Billion ≈ $11.81 Billion |
+3.67% |
| 2023-12-31 | €9.75 Billion ≈ $11.39 Billion |
+39.67% |
| 2022-12-31 | €6.98 Billion ≈ $8.16 Billion |
-- |
About SARTORIUS (UNSP.ADS)/1/5
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more